2026 Q2 Portfolio Activity
In 2026 Q2, FCPM III SERVICES B.V. maintained a portfolio of 11 distinct positions. The most significant new addition was AURA BIOSCIENCES INC, now representing 3.84% of the total fund value.
Position History
hover any row below to update
Loading…
Total Positions
11
Quarter
2026 Q2
Top Holding
NAMS (38.3%)
Top 10 Concentration
99.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-11 of 11
FCPM III SERVICES B.V. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 38.34% | 40.77% |
#1
Prev: #1
|
6.5 |
—
|
-708,547 | -7.7% |
P
S
|
8,490,353 | $287,738,063 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 15.41% | 9.08% |
#2
3
Prev: #5
|
6.5 |
—
|
no change | no change |
P
S
|
3,226,400 | $115,634,176 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 11.39% | 11.66% |
#3
1
Prev: #2
|
5.5 |
—
|
-796,130 | -17.1% |
P
S
|
3,848,256 | $85,469,766 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 10.10% | 10.17% |
#4
1
Prev: #3
|
5.5 |
—
|
no change | no change |
P
S
|
4,117,354 | $75,800,487 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 8.46% | 8.75% |
#5
1
Prev: #6
|
4.9 |
—
|
no change | no change |
P
S
|
2,441,000 | $63,490,410 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 4.14% | 2.97% |
#6
2
Prev: #8
|
2.7 |
—
|
no change | no change |
P
S
|
2,808,368 | $31,088,634 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 4.02% | 4.27% |
#7
Prev: #7
|
2.6 |
—
|
no change | no change |
P
S
|
1,677,852 | $30,201,336 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 3.84% | — |
#8
Prev: #—
|
5.0 |
—
|
4,053,775 | — |
NEW
|
4,053,775 | $28,781,803 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 2.22% | 9.08% |
#9
5
Prev: #4
|
1.9 |
—
|
no change | no change |
P
S
|
9,632,561 | $16,664,330 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCYC
BICYCLE THERAPE...
|
Healthcare | 1.96% | 2.23% |
#10
1
Prev: #9
|
1.8 |
—
|
no change | no change |
P
S
|
3,468,430 | $14,706,143 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENGNW
ENGENE HOLDINGS...
|
Unknown | 0.11% | 1.01% |
#11
1
Prev: #10
|
1.0 |
—
|
no change | no change |
P
S
|
2,878,148 | $834,376 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-11 of 11 holdings